Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine vs Azacitidine in Intermediate or High Risk MDS
NCT01011283Phase 4Terminated
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of decitabine in myelodysplastic syndrome (MDS), sponsored by Eisai Co., Ltd.. Started Nov 2009; status: terminated.
02
Drugs
decitabine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT01011283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01011283.